Literature DB >> 2185490

Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

J F Borel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185490

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  23 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

3.  Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.

Authors:  C A Harrison; R Bastan; M J Peirce; M R Munday; P T Peachell
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

4.  Cyclosporin: use outside transplantation.

Authors:  A W Thomson; G H Neild
Journal:  BMJ       Date:  1991-01-05

5.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain.

Authors:  V Mikol; J Kallen; M D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidney.

Authors:  Guillermo Suñé; Eduard Sarró; Marta Puigmulé; Joan López-Hellín; Madeleine Zufferey; Thomas Pertel; Jeremy Luban; Anna Meseguer
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Interleukin-8 is a cyclosporin A binding protein.

Authors:  H Bang; K Brune; C Nager; U Feige
Journal:  Experientia       Date:  1993-07-05

Review 10.  Mechanism of action of cyclosporin in rheumatoid arthritis.

Authors:  J Bentin
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.